Cyproheptadine in the control of Cushing's disease
- PMID: 6265685
Cyproheptadine in the control of Cushing's disease
Abstract
A patient with Cushing's disease was treated with cyproheptadine with concomitant remission of the disease for 60 months. Despite clinical improvement and achievement of normal levels of cortisol excretions, her menstruation-related cyclic surge of cortisol secretion was supranormal. The mode of action of cyproheptadine was studied by the administration of metyrapone. Long-term administration of cyproheptadine appeared to normalize excessive adrenocorticotropic hormone (ACTH) production by reducing the frequency and the peak levels of episodic secretion of ACTH.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical